Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) – New vaccine approval
February 15, 2025 - GSK announced the FDA approval of Penmenvy (meningococcal groups A, B, C, W, and Y vaccine), for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y in individuals 10 through 25 years of age.
Top